The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2019)
Open accessAbstract
Diabetes mellitus bezeichnet eine Gruppe von heterogenen Erkrankungen, deren gemeinsamer Befund die Erhöhung der Blutglukosekonzentration ist. Die gegenwärtige Klassifikation des Diabetes mellitus wird dargestellt, und die wesentlichen Merkmale von Typ-1- und Typ-2-Diabetes werden gegenübergestellt. Darüber hinaus werden die Kriterien für die korrekte biochemische Diagnose unter Nüchternbedingungen und im oralen Glukosetoleranztest sowie die Anwendung des Hämoglobin A1c (HbA1c) zusammengefasst. Die zunehmende Prävalenz des Diabetes erfordert zudem gezieltes Screening zur Erkennung von Diabetes und Prädiabetes in Risikogruppen. Dies bildete die Grundlage für die frühzeitige Einleitung von Maßnahmen zur Prävention der Manifestation des Diabetes in diesen Risikogruppen und Verzögerung der Diabetesprogression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436
Ahlqvist, E., Storm, P., Käräjämäki, A., Martinell, M., Dorkhan, M., Carlsson, A., Vikman, P., Prasad, R. B., Aly, D. M., Almgren, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30051-2 · Cited by 2,335
Mozaffarian, D. (2016) · Circulation · doi:10.1161/circulationaha.115.018585 · Cited by 2,216
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.155 · Cited by 1,915
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Basal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624
Li, G., Zhang, P., Wang, J., Gregg, E. W., Yang, W., Gong, Q., Li, H., Li, H., Jiang, Y., An, Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60766-7 · Cited by 1,600
Huang, Y., Cai, X., Mai, W., Li, M., & Hu, Y. (2016) · BMJ · doi:10.1136/bmj.i5953 · Cited by 1,012
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
DeFronzo, R. A., Tripathy, D., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., Henry, R. R., Hodis, H. N., Kitabchi, A. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010949 · Cited by 766
Effect of ramipril on the incidence of diabetes
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa065061 · Cited by 737
Li, G., Zhang, P., Wang, J., An, Y., Gong, Q., Gregg, E. W., Yang, W., Zhang, B., Shuai, Y., Hong, J., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70057-9 · Cited by 684
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), & European Association for the Study of Obesity (EASO) (2016) · Diabetologia · doi:10.1007/s00125-016-3902-y · Cited by 683
Effect of valsartan on the incidence of diabetes and cardiovascular events
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001121 · Cited by 660
Gong, Q., Zhang, P., Wang, J., Ma, J., An, Y., Chen, Y., Zhang, B., Feng, X., Li, H., Chen, X., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30093-2 · Cited by 615
Zaharia, O. P., Strassburger, K., Strom, A., Bönhof, G. J., Karusheva, Y., Antoniou, S., Bódis, K., Markgraf, D. F., Burkart, V., Müssig, K., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30187-1 · Cited by 600 · cited 1×
“…Stadium Rezente Studien schlagen eine weitere Klassifizie-rung des Typ-2-Diabetes in Subtypen (Endotypen) auf Basis unterschiedlicher Phänotypen [9, 10] oder auch Genotypen [11, 12] vor, die Unterschiede im Ausmaß der Insulinresistenz und Betazellfunktion sowie Risi-ken für Diabetes-bedingte…”
Self-citationIDF Diabetes Atlas 9th Edition
Diabetes Federation (2019) · Cited by 581
Early Infant Feeding and Risk of Developing Type 1 Diabetes–Associated Autoantibodies
Ziegler, A.-G. (2003) · JAMA · doi:10.1001/jama.290.13.1721 · Cited by 570
4. Lifestyle Management: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s004 · Cited by 563
Timing of initial cereal exposure in infancy and risk of islet autoimmunity
Norris, J. M. (2003) · JAMA · doi:10.1001/jama.290.13.1713 · Cited by 515
Afshin, A., Micha, R., Khatibzadeh, S., & Mozaffarian, D. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.076901 · Cited by 509
Effect of nateglinide on the incidence of diabetes and cardiovascular events
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001122 · Cited by 477
Abuissa, H., Jones, P. G., Marso, S. P., & O’Keefe, J. H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.051 · Cited by 452
Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis
Chen, M., Sun, Q., Giovannucci, E., Mozaffarian, D., Manson, J. E., Willett, W. C., & Hu, F. B. (2014) · BMC Medicine · doi:10.1186/s12916-014-0215-1 · Cited by 370
Haw, J. S., Galaviz, K. I., Straus, A. N., Kowalski, A. J., Magee, M. J., Weber, M. B., Wei, J., Narayan, K. M. V., & Ali, M. K. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.6040 · Cited by 354
Kawamori, R., Tajima, N., Iwamoto, Y., Kashiwagi, A., Shimamoto, K., & Kaku, K. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60222-1 · Cited by 303
Saito, T. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.275 · Cited by 277
Teplizumab and β-cell function in newly diagnosed type 1 diabetes
Ramos, E. L., Dayan, C. M., Chatenoud, L., Sumnik, Z., Simmons, K. M., Szypowska, A., Gitelman, S. E., Knecht, L. A., Niemoeller, E., Tian, W., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2308743 · Cited by 273
Zinman, B., Harris, S. B., Neuman, J., Gerstein, H. C., Retnakaran, R. R., Raboud, J., Qi, Y., & Hanley, A. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60746-5 · Cited by 235
5. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc18-s005 · Cited by 212
Impact of 3‐year lifestyle intervention on postprandial glucose metabolism: the SLIM study
Roumen, C., Corpeleijn, E., Feskens, E. J. M., Mensink, M., Saris, W. H. M., & Blaak, E. E. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02417.x · Cited by 187
Panunzi, S., De Gaetano, A., Carnicelli, A., & Mingrone, G. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000000863 · Cited by 185
Definition, Klassifikation und Diagnostik des Diabetes mellitus
Nauck, M., Petermann, A., Müller-Wieland, D., Kerner, W., Müller, U., Landgraf, R., Freckmann, G., & Heinemann, L. (2017) · Diabetologie und Stoffwechsel · doi:10.1055/s-0043-115953 · Cited by 175
Dungan, J. S. (2011) · Yearbook of Obstetrics, Gynecology and Women's Health · doi:10.1016/j.yobg.2011.05.175 · Cited by 173
Mursu, J., Virtanen, J. K., Tuomainen, T.-P., Nurmi, T., & Voutilainen, S. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.069641 · Cited by 165
Penn, L., White, M. J., Oldroyd, J. C., Walker, M., Alberti, K. G. M. M., & Mathers, J. C. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-342 · Cited by 158
Sakane, N., Sato, J., Tsushita, K., Tsujii, S., Kotani, K., Tsuzaki, K., Tominaga, M., Kawazu, S., Sato, Y., Usui, T., et al. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-40 · Cited by 151
Haller, M. J., Bell, K. J., Besser, R. E. J., Casteels, K., Couper, J. J., Craig, M. E., Elding Larsson, H., Jacobsen, L., Lange, K., Oron, T., et al. (2024) · Hormone Research in Paediatrics · doi:10.1159/000543035 · Cited by 151
Diabetes mellitus – Definition, Klassifikation und Diagnose
Roden, M. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-015-0931-3 · Cited by 142
Self-citationDisturbed Glucoregulatory Response to Food Intake After Moderate Sleep Restriction
Schmid, S. M., Hallschmid, M., Jauch-Chara, K., Wilms, B., Lehnert, H., Born, J., & Schultes, B. (2011) · Sleep · doi:10.1093/sleep/34.3.371 · Cited by 140
Sex and Gender Differences in Prevention of Type 2 Diabetes
Harreiter, J., & Kautzky‐Willer, A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00220 · Cited by 140
Self-citationGlycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus—Practical implications
Colagiuri, S. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.06.025 · Cited by 126
The effect of technology-mediated diabetes prevention interventions on weight: a meta-analysis
Bian, R. R., Piatt, G. A., Sen, A., Plegue, M. A., De Michele, M. L., Hafez, D., Czuhajewski, C. M., Buis, L. R., Kaufman, N., & Richardson, C. R. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.4709 · Cited by 99
Kowall, B., Rathmann, W., Straßburger, K., Heier, M., Holle, R., Thorand, B., Giani, G., Peters, A., & Meisinger, C. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9452-6 · Cited by 99
Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients
Tenenbaum, A., Motro, M., Fisman, E. Z., Adler, Y., Shemesh, J., Tanné, D., Leor, J., Boyko, V., Schwammenthal, E., & Behar, S. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi310 · Cited by 91
Sex-specific differences in diabetes prevention: a systematic review and meta-analysis
Glechner, A., Harreiter, J., Gartlehner, G., Rohleder, S., Kautzky, A., Tuomilehto, J. O., Noord, M. V., Kaminski-Hartenthaler, A., & Kautzky‐Willer, A. (2014) · Diabetologia · doi:10.1007/s00125-014-3439-x · Cited by 61
Self-citationKowall, B., & Rathmann, W. (2013) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s39093 · Cited by 60
Vaarala, O., Klemetti, P., Juhela, S., Simell, O., Hyöty, H., & Ilonen, J. (2002) · Diabetologia · doi:10.1007/s00125-002-0787-8 · Cited by 50
Roberts, S., Craig, D., Adler, A., McPherson, K., & Greenhalgh, T. (2018) · BMC Medicine · doi:10.1186/s12916-017-0984-4 · Cited by 48
Diabetes mellitus – Definition, Klassifikation und Diagnose
Roden, M. (2012) · Wiener klinische Wochenschrift · doi:10.1007/s00508-012-0269-z · Cited by 36
Self-citationLindblad, U., Lindberg, G., Månsson, N. ‐., Ranstam, J., Tyrberg, M., Jansson, S. P. O., Lindwall, K., Svärdh, M., Kindmalm, L., & Melander, A. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01331.x · Cited by 19
JDRF's vision and strategy for prevention of type 1 diabetes
Insel, R. A., & Dunne, J. L. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12326 · Cited by 19
Towards a coxsackievirus B-based vaccine to combat T1DM
Hober, D., & Alidjinou, E. K. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.184 · Cited by 7
Cited by
Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
Wang, M., Tan, Y., Shi, Y., Wang, X., Liao, Z., & Wei, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00568 · Cited by 231
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer
Ibrahim, S. S., Ibrahim, R. S., Arabi, B., Brockmueller, A., Shakibaei, M., & Büsselberg, D. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10192-9 · Cited by 56
Ansari, P., Khan, J. T., Choudhary, S., Reberio, A. D., Kumar, S., Seidel, V., Abdel-Wahab, Y. H. A., & Flatt, P. R. (2024) · doi:10.20944/preprints202408.1739.v1 · Cited by 89
Metadata
- Authors
- Harreiter, J., & Roden, M.
- Venue
- Wiener klinische Wochenschrift
- Published
- 2019-04-12
- Volume
- 131
- Issue
- S1
- Pages
- 6-15
- ISSN
- 0043-5325 (ISSN-L)
- 1613-7671
- OpenAlex
- W2936041668
- Cited by
- 253
- References
- 60
- FWCI
- 16.69
- Type
- journal article
- Language
- de
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.